Documented rheumatic disease was associated with higher post-discharge mortality after ACS (adjusted HR 1.56; 95% CI 1.04-2.34), though the association attenuated in broader exploratory adjustment.
Cohort (n=2,950)
Yes
Does documented rheumatic disease increase post-discharge all-cause mortality in patients undergoing coronary angiography for acute coronary syndrome?
Documented rheumatic disease in ACS patients is associated with greater psychiatric comorbidity and potentially worse post-discharge survival, though the mortality risk attenuates after broader adjustment.
Hazard Ratio: 1.56 (95% CI 1.04–2.34)
Absolute Event Rate: 27.4% vs 19.3%
p-value: p=0.013
Background and Objectives: Rheumatic diseases confer excess cardiovascular risk, yet prognosis after acute coronary syndrome (ACS) in contemporary angiography-treated care remains incompletely characterized, particularly when psychiatric multimorbidity is considered. We evaluated whether documented rheumatic disease was associated with psychiatric comorbidity and post-discharge mortality after ACS. Materials and Methods: We retrospectively analyzed a predefined two-center registry extract of 2950 consecutive patients who underwent coronary angiography for ACS. Documented rheumatic disease was identified from diagnoses recorded in admission history, prior medical records, or discharge documentation and was not re-adjudicated. The primary outcome was post-discharge all-cause mortality. Results: Documented rheumatic disease was present in 106 patients (3.6%). Compared with patients without documented rheumatic disease, exposed patients were older, more often women, more often hypertensive, and more likely to have a documented psychiatric disorder (25.5% vs. 14.1%). Short-term mortality was similar, whereas crude overall long-term mortality was higher (27.4% vs. 19.3%). Among hospital survivors with usable follow-up, post-discharge survival was worse (log-rank p = 0.013). Documented rheumatic disease was associated with higher post-discharge mortality in unadjusted analysis (hazard ratio 1.66, 95% confidence interval 1.11–2.48) and in a prespecified parsimonious model (adjusted hazard ratio 1.56, 95% confidence interval 1.04–2.34); the association attenuated and was no longer statistically significant in a broader exploratory model (adjusted hazard ratio 1.35, 95% confidence interval 0.87–2.07). Documented psychiatric disorder independently predicted mortality. Conclusions: In angiography-treated ACS, documented rheumatic disease was associated with greater psychiatric comorbidity and worse post-discharge survival in a small, documentation-defined, heterogeneous subgroup. Because the signal attenuated in broader exploratory adjustment and exposure ascertainment was documentation-based, the findings should be regarded as hypothesis-generating rather than disease-specific or causal.
Jurin et al. (Mon,) conducted a cohort in Acute Coronary Syndrome (n=2,950). Documented rheumatic disease vs. No documented rheumatic disease was evaluated on post-discharge all-cause mortality (adjusted HR 1.56, 95% CI 1.04-2.34, p=0.013). Documented rheumatic disease was associated with higher post-discharge mortality after ACS (adjusted HR 1.56; 95% CI 1.04-2.34), though the association attenuated in broader exploratory adjustment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: